Here is the optimized content for the Rifampicin + Isoniazid (Fixcom 2) 150mg/75mg Tablet (Box of 80s) for your website:
Rifampicin + Isoniazid (Fixcom 2) is a potent fixed-dose combination (FDC) therapy specifically designed for the continuation phase of short-course chemotherapy for Tuberculosis (TB). Indicated for both pulmonary and extrapulmonary tuberculosis, this dual-action medication simplifies treatment by combining two of the most powerful bactericidal agents into a single film-coated tablet.
This formulation works through the synergistic action of its active ingredients:
-
Rifampicin (150mg): A powerful antibiotic that inhibits bacterial RNA synthesis, effectively killing actively dividing and semi-dormant Mycobacterium tuberculosis bacilli. It is considered the most potent sterilizing drug available.
-
Isoniazid (75mg): A primary antituberculosis drug that interferes with the cell wall synthesis of the bacteria. It is highly bactericidal against rapidly growing bacilli.
By using the Fixcom 2 combination, patients benefit from a reduced pill burden, which significantly improves treatment compliance and helps prevent the development of multi-drug resistant TB (MDR-TB). This product is manufactured by Lloyd Laboratories, Inc. for Natrapharm, Inc., ensuring high-quality standards for respiratory health in the Philippines.
Key Benefits:
-
Optimized Continuation Phase Therapy: Specifically formulated for the 4-month continuation phase of TB treatment.
-
Synergistic Bactericidal Action: Dual-action formula ensures the thorough eradication of TB bacilli.
-
Improved Compliance: The fixed-dose combination reduces the number of tablets needed daily, making it easier to complete the full course of treatment.
-
Simplifies Medication Regimen: Prevents the confusion of taking multiple separate drugs, ensuring the correct ratio of Rifampicin and Isoniazid is consumed.
-
Value Box (80s): Convenient packaging to support a consistent and uninterrupted treatment schedule.





